The in vitro diagnostics market - Italy

In vitro diagnostics are an essential part of health care, which can provide critical information at every stage of the patient's journey, from prognosis, screening, diagnosis, monitoring disease progression, and predicting treatment responses, contributing to the available medical information regarding a patient, enabling early and targeted treatments, and helping to reduce hospital stays and convalescence, and improving the well-being of the general public.it has been estimated that the results of in vitro diagnostic tests influence up to 70 percent of clinical decisions, while accounting for only 0.8 percent of total health care expenditures.In vitro diagnostic medical devices (IVDs) can consist of devices (e.g., reagent equipment kits) that are simple or of sophisticated technology to perform assays on samples taken from the human body (e.g., blood, urine, saliva, and tissues taken by biopsy). They can be used in different settings ranging from Testing Laboratories, to the home environment for self-tests (e.g., glucose meters) that can be used directly by the patient (lay user). In 2023 the global in vitro diagnostic (IVD) market is estimated at 97.$12 billion. Sustained growth of the industry is expected in the near future. For the period 2024-2030 a compound annual growth rate is estimated (CAGR) of 7.1 percent under which the global market could reach a total value of more than 156 billion dollars.As for the European market, this reached a value of $25.36 billion in 2022. This study focuses on the specific in vitro diagnostic (IVD) market in Italy, analyzing consumption trends, competitive dynamics, and growth prospects for the sector. For information on related markets, such as medical biology laboratories, see the specific studies available in the Businesscoot catalog.